Revised forecast
Fiscal year ending March 2026 · Full year (1 April 2025 to 31 March 2026)The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Net sales were below the previous fiscal year's results due to the termination of the pigment-grade titanium dioxide business and the impact of the slowdown of the Chinese economy and other factors in the cosmetics materials segment. Although the electronic materials segment and other businesses remained firm, resulting in operating profit and ordinary profit exceeding the previous fiscal year's results, net income declined because an impairment loss of ¥2,967 million on cosmetics materials manufacturing equipment was recorded as an extraordinary loss and the previous fiscal year's ¥2,371 million gain on the elimination of shares held in a merger was reversed.
Impairment loss on cosmetics materials manufacturing equipment: ¥2,967 million
| Item | Details |
|---|---|
| Net Sales | -2,708 |
| Operating profit | 155 |
| Ordinary income | 541 |
| Profit attributable to owners of the parent | -5,437 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year (1 April 2025 to 31 March 2026) |
| Previous-period results | Net sales: ¥44,342 million; operating profit: ¥2,655 million; ordinary profit: ¥3,405 million; net income: ¥6,235 million; net income per share: ¥384.56 |
| Reason for the revision | Net sales were below the previous fiscal year's results due to the termination of the pigment-grade titanium dioxide business and the impact of the slowdown of the Chinese economy and other factors in the cosmetics materials segment. Although the electronic materials segment and other businesses remained firm, resulting in operating profit and ordinary profit exceeding the previous fiscal year's results, net income declined because an impairment loss of ¥2,967 million on cosmetics materials manufacturing equipment was recorded as an extraordinary loss and the previous fiscal year's ¥2,371 million gain on the elimination of shares held in a merger was reversed. |
| Details and amount of extraordinary loss | Impairment loss on cosmetics materials manufacturing equipment: ¥2,967 million |
| Consolidated / non-consolidated | Non-consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales declined due to the termination of the pigment-grade titanium dioxide business and the slowdown of the Chinese economy and other factors in the cosmetics materials segment. Operating profit and ordinary profit increased as the electronic materials segment and other businesses remained firm, but net income declined due to an impairment loss of ¥2,967 million on cosmetics materials manufacturing equipment and the reversal of the ¥2,371 million gain on the elimination of shares held in a merger recognized in the previous fiscal year.